Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/25105
DC FieldValue
dc.titleEnhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
dc.contributor.authorZhou, J.
dc.contributor.authorBi, C.
dc.contributor.authorJanakakumara, J.V.
dc.contributor.authorLiu, S.-C.
dc.contributor.authorChng, W.-J.
dc.contributor.authorTay, K.-G.
dc.contributor.authorPoon, L.-F.
dc.contributor.authorXie, Z.
dc.contributor.authorPalaniyandi, S.
dc.contributor.authorChen, C.-S.
dc.contributor.authorYu, H.
dc.contributor.authorGlaser, K.B.
dc.contributor.authorAlbert, D.H.
dc.contributor.authorDavidsen, S.K.
dc.date.accessioned2011-08-01T03:04:55Z
dc.date.available2011-08-01T03:04:55Z
dc.date.issued2009
dc.identifier.citationZhou, J., Bi, C., Janakakumara, J.V., Liu, S.-C., Chng, W.-J., Tay, K.-G., Poon, L.-F., Xie, Z., Palaniyandi, S., Chen, C.-S., Yu, H., Glaser, K.B., Albert, D.H., Davidsen, S.K. (2009). Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood 113 (17) : 4052-4062. ScholarBank@NUS Repository.
dc.identifier.issn00064971
dc.identifier.issn15280020
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/25105
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1182/blood-2008-05-156422
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentPHYSIOLOGY
dc.contributor.departmentMEDICINE
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.sourcetitleBlood
dc.description.volume113
dc.description.issue17
dc.description.page4052-4062
dc.identifier.isiut000265447000025
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.